The Creso Pharma [ASX:CPH] share price is falling as ASIC probes EverBlu Capital, whose executive chairman also serves as CPH’s non-executive chair and co-founder.
The Creso Pharma [ASX:CPH] shares soared in early morning trade after the company announced its wholly-owned Canadian subsidiary, Mernova, secured over $800,000 in new purchase orders.
The Creso Pharma Ltd [ASX:CPH] share price is up 9% after the release of its June quarter results. The CPH share price were trading for 12 cents at time of writing...
Pot stock Creso Pharma [ASX:CPH] is on the up today. Shares are trading 1.54% higher as the company announced some new developments from its Canadian subsidiary: Halucenex...
The Creso Pharma Ltd [ASX:CPH] share price jumped 12% after the pot stock completed its US OTC dual listing. CPH shares were up as much as 15% in early trade...
The CPH share price is down 2.6%. Creso Pharma Ltd [ASX:CPH] came out of a trading halt to announce its acquisition target Halucenex has upped its psilocybin inventory...